Sepsis constitutes a global burden on medical care and accounts for nearly 20% of reported global mortality.1 The development of sepsis is complex, though the triggering of a disproportional systemic proinflammatory response is considered pivotal in driving organ dysfunction and subsequent mortality. As functional pattern recognition receptors, toll-like receptors (TLRs) play a predominant role in this context. Hence, approaches aimed at limiting their activation are considered valuable strategies for mitigating the organ damage and mortality occurring during the advancement of sepsis.
Cani, P., Van Hul, M., & Bachmann, R. (2023). Akkermansia muciniphila derived tripeptide jams the gear of sepsis, inflammation and mortality. Gut, 73(1), 3-4. https://doi.org/10.1136/gutjnl-2023-331092 (Original work published 2023)